Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Radiology
Published in: European Radiology 5/2014

01-05-2014 | Urogenital

Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours

Authors: F. Cornelis, E. Tricaud, A. S. Lasserre, F. Petitpierre, J. C. Bernhard, Y. Le Bras, M. Yacoub, M. Bouzgarrou, A. Ravaud, N. Grenier

Published in: European Radiology | Issue 5/2014

Login to get access

Abstract

Objectives

To retrospectively evaluate the ability of multiparametric magnetic resonance (MR) imaging to differentiate renal tumours.

Methods

MR images from 100 consecutive pathologically proven solid renal tumours without macroscopic fat [57 clear cell, 16 papillary and 7 chromophobe renal cell carcinomas (RCCs), 16 oncocytomas and 4 minimal fat angiomyolipomas (AMLs)] between 2009 and 2012 were evaluated. Two radiologists blinded to pathology results independently reviewed double-echo chemical shift, dynamic contrast-enhanced T1- and T2-weighted images and apparent diffusion coefficient (ADC) maps. Signal intensity index (SII), tumour-to-spleen SI ratio (TSR), ADC ratio, wash-in (WiI) and wash-out indices (WoI) between different phases were calculated.

Results

There were significant differences between papillary RCCs and other renal tumours for arterial WiI (P < 0.001), initial WoI (P = 0.006) and ADC ratio (P < 0.001); between chromophobe RCCs and oncocytomas for TSR (P = 0.02), parenchymal WiI (P = 0.03), late WiI (P = 0.02), initial WoI (P = 0.03) and late WoI (P = 0.04); and between clear cell RCCs and oncocytomas for SII (P = 0.01) and parenchymal WiI (P = 0.01). Papillary RCCs were distinguished from other tumours (sensitivity 37.5 %, specificity 100 %) and oncocytomas from chromophobe RCCs (sensitivity 25 %, specificity 100 %) and clear cell RCCs (sensitivity 100 %, specificity 94.2 %).

Conclusion

MR imaging provides criteria able to accurately distinguish papillary RCCs from other tumours and oncocytomas from chromophobe and clear cell RCCs.

Key Points

• Multiparametric MR parameters accurately distinguish papillary RCCs with high specificity (100 %).
• Oncocytomas can be distinguished from chromophobe RCCs with high specificity (100 %).
• Oncocytomas can be distinguished from clear cell RCCs with high specificity (94.2 %).
• In oncocytomatosis, imaging follow-up with such parameters analysis could be promoted.
Literature
1.
Lechevallier E, Andre M, Barriol D et al (2000) Fine-needle percutaneous biopsy of renal masses with helical CT guidance. Radiology 216:506–510PubMedCrossRef
2.
Eshed I, Elias S, Sidi AA (2004) Diagnostic value of CT-guided biopsy of indeterminate renal masses. Clin Radiol 59:262–267PubMedCrossRef
3.
Fujii Y, Komai Y, Saito K et al (2008) Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology 72:598–602PubMedCrossRef
4.
Snyder ME, Bach A, Kattan MW, Raj GV, Reuter VE, Russo P (2006) Incidence of benign lesions for clinically localized renal masses smaller than 7 cm in radiological diameter: influence of sex. J Urol 176:2391–2395PubMedCrossRef
5.
Breda A, Treat EG, Haft-Candell L et al (2010) Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study. BJU Int 105:940–945PubMedCrossRef
6.
Herts BR, Baker ME (1995) The current role of percutaneous biopsy in the evaluation of renal masses. Semin Urol Oncol 13:254–261PubMed
7.
Heilbrun ME, Zagoria RJ, Garvin AJ et al (2007) CT-guided biopsy for the diagnosis of renal tumors before treatment with percutaneous ablation. AJR 188:1500–1505PubMedCrossRef
8.
Milner J, McNeil B, Alioto J et al (2006) Fat poor renal angiomyolipoma: patient, computerized tomography and histological findings. J Urol 176:905–909PubMedCrossRef
9.
Bosniak MA, Megibow AJ, Hulnick DH, Horii S, Raghavendra BN (1988) CT diagnosis of renal angiomyolipoma: the importance of detecting small amounts of fat. AJR 151:497–501PubMedCrossRef
10.
Kim JK, Kim SH, Jang YJ et al (2006) Renal angiomyolipoma with minimal fat: differentiation from other neoplasms at double-echo chemical shift FLASH MR imaging. Radiology 239:174–180PubMedCrossRef
11.
Hindman N, Ngo L, Genega EM et al (2012) Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology 265:468–477PubMedCentralPubMedCrossRef
12.
Yoshimitsu K, Irie H, Tajima T et al (2004) MR imaging of renal cell carcinoma: its role in determining cell type. Radiat Med 22:371–376PubMed
13.
Oliva MR, Glickman JN, Zou KH et al (2009) Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology. AJR 192:1524–1530PubMedCrossRef
14.
Roy C, Sauer B, Lindner V, Lang H, Saussine C, Jacqmin D (2007) MR imaging of papillary renal neoplasms: potential application for characterization of small renal masses. Eur Radiol 17:193–200PubMedCrossRef
15.
Rosenkrantz AB, Niver BE, Fitzgerald EF, Babb JS, Chandarana H, Melamed J (2010) Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade. AJR 195:W344–351PubMedCrossRef
16.
Zhang JL, Sigmund EE, Chandarana H et al (2010) Variability of renal apparent diffusion coefficients: limitations of the monoexponential model for diffusion quantification. Radiology 254:783–792PubMedCentralPubMedCrossRef
17.
Cornelis F, Lasserre AS, Tourdias T et al (2013) Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central t2 signal intensity from renal cell carcinomas. AJR 200:830–838PubMedCrossRef
18.
Sasiwimonphan K, Takahashi N, Leibovich BC, Carter RE, Atwell TD, Kawashima A (2012) Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology 263:160–168PubMedCrossRef
19.
Busing KA, Kilian AK, Schaible T, Debus A, Weiss C, Neff KW (2008) Reliability and validity of MR image lung volume measurement in fetuses with congenital diaphragmatic hernia and in vitro lung models. Radiology 246:553–561PubMedCrossRef
20.
Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420–428PubMedCrossRef
21.
22.
23.
Pedrosa I, Sun MR, Spencer M et al (2008) MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. Radiographics 28:985–1003PubMedCrossRef
24.
Sun MRM, Ngo L, Genega EM et al (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes–correlation with pathologic findings. Radiology 250:793–802PubMedCrossRef
25.
Vargas HA, Chaim J, Lefkowitz RA et al (2012) Renal cortical tumors: use of multiphasic contrast-enhanced MR imaging to differentiate benign and malignant histologic subtypes. Radiology 264:779–788PubMedCrossRef
26.
Wang H, Cheng L, Zhang X et al (2010) Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T. Radiology 257:135–143PubMedCrossRef
27.
Pedrosa I, Alsop DC, Rofsky NM (2009) Magnetic resonance imaging as a biomarker in renal cell carcinoma. Cancer 115:2334–2345PubMedCrossRef
28.
29.
Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS (2010) MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR 195:W421–427PubMedCrossRef
30.
Dodelzon K, Mussi TC, Babb JS, Taneja SS, Rosenkrantz AB (2012) Prediction of growth rate of solid renal masses: utility of MR imaging features–preliminary experience. Radiology 262:884–893PubMedCrossRef
31.
Harmon WJ, King BF, Lieber MM (1996) Renal oncocytoma: magnetic resonance imaging characteristics. J Urol 155:863–867PubMedCrossRef
32.
Millet I, Doyon FC, Hoa D et al (2011) Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? AJR 197:887–896PubMedCrossRef
33.
Vargas HA, Delaney HG, Delappe EM et al (2013) Multiphasic contrast-enhanced MRI: single-slice versus volumetric quantification of tumor enhancement for the assessment of renal clear-cell carcinoma fuhrman grade. J Magn Reson Imaging 37:1160–1167PubMedCrossRef
Metadata
Title
Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours
Authors
F. Cornelis
E. Tricaud
A. S. Lasserre
F. Petitpierre
J. C. Bernhard
Y. Le Bras
M. Yacoub
M. Bouzgarrou
A. Ravaud
N. Grenier
Publication date
01-05-2014
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 5/2014
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3107-z

Other articles of this Issue 5/2014

European Radiology 5/2014 Go to the issue

Oncology

Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer

Computed Tomography

Emergency CT head and neck imaging: effects of swimmer’s position on dose and image quality

Computed Tomography

Assessment of vascular contrast and wall motion of the aortic root and ascending aorta on MDCT angiography: dual-source high-pitch vs non-gated single-source acquisition schemes

Magnetic Resonance

Multi-delay arterial spin labeling perfusion MRI in moyamoya disease–comparison with CT perfusion imaging

Gastrointestinal

Sensitivity and specificity of CT colonography for the detection of colonic neoplasia after positive faecal occult blood testing: systematic review and meta-analysis

Hepatobiliary-Pancreas

Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla